Skip to main content

Pro Dex Inc

PDEX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000788920

In the last 90 days, Pro Dex Inc insiders filed 0 open-market purchases and 4 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $43.0M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.40M in total
4
13F holdersQ2 2026, +9 vs. previous quarter
66
13F valueReported value at the end of Q2 2026
$43.0M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding PDEX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PDEX at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Pro Dex Inc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)7:30 PM ETSep 113 daysVan Kirk Richard Lee JrChief Executive OfficerSSale−765$59.36−$45.4K−1.0%79.2K after2 lots10b5-1
Sep 10, 2026 (view filing)8:20 PM ETSep 91 dayVan Kirk Richard Lee JrChief Executive OfficerSSale−19.2K$60.58−$1.17M−19.4%80.0K after9 lots10b5-1
Sep 10, 2026 (view filing)8:19 PM ETSep 91 dayCharlton AlishaChief Financial OfficerSSale−2.30K$61.30−$141.0K−9.5%21.9K after2 lots
Jul 14, 2026 (view filing)6:00 PM ETMar 16120 daysLateDomingo Angelita RebamontanDirectorSSale−998$47.24−$47.1K−5.0%18.8K after
May 26, 2026 (view filing)May 21-225 daysVan Kirk Richard Lee JrChief Executive OfficerSSale−10.0K$62.62−$626.2K−10.0%89.7K after6 lots10b5-1
Apr 4, 2025 (view filing)Apr 22 daysSwenson Nicholas JohnDirector, 10% OwnerSSale−4.53K––−0.5%922.2K after2 lots
Apr 1, 2025 (view filing)6:55 PM ETApr 1Same dayCabillot Raymond E and 1 otherDirector, 10% OwnerSSale−7.26K$50.01−$363.2K−2.6%270.8K after10b5-1
Mar 31, 2025 (view filing)9:01 PM ETMar 28-313 daysCabillot Raymond E and 1 otherDirector, 10% OwnerSSale−1.68K$50.00−$83.9K−0.6%278.1K after2 lots10b5-1
Mar 27, 2025 (view filing)7:18 PM ETMar 261 dayCabillot Raymond E and 1 otherDirector, 10% OwnerSSale−3.10K$50.13−$155.2K−1.1%279.8K after10b5-1
Mar 25, 2025 (view filing)7:40 PM ETMar 24-251 dayCabillot Raymond E and 1 otherDirector, 10% OwnerSSale−15.7K$50.23−$789.2K−5.3%282.9K after3 lots10b5-1

Top 10 13F holders, Q2 2026

The largest institutional positions in Pro Dex Inc at the end of Q2 2026; share changes are against Q1 2026.

See all 66 holders
Institutions holding PDEX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.153,178$8.97M0.00%+663+0.4%Added
Vanguard Capital Management LLC82,283$4.82M0.00%−29,047−26.1%Reduced
Dimensional Fund Advisors LP57,061$3.34M0.00%+120+0.2%Added
Punch & Associates Investment Management, Inc.52,735$3.09M0.15%−9,000−14.6%Reduced
Geode Capital Management, LLC49,636$2.91M0.00%+1,289+2.7%Added
JPMorgan Chase & Co32,287$1.89M0.00%+251+0.8%Added
State Street Corp31,310$1.83M0.00%−1,804−5.4%Reduced
Goldman Sachs Group Inc18,711$1.10M0.00%+8,570+84.5%Added
Pekin Hardy Strauss, Inc.16,500$966.1K0.09%+16,500New
BNP Paribas Arbitrage, SA15,945$933.6K0.00%+2,711+20.5%Added